SpaceX's First Big Lockup Tranche Passes Without a Selloff

On August 6, 2026, SpaceX's first major post-IPO lockup tranche expired, making up to 911.5 million shares, roughly $100 billion at recent prices, eligible for sale. That more than doubled the publicly tradable float. Instead of the heavy selling pressure many had predicted, SPCX shares closed up about 6.1% at $114.92 on elevated volume of over 250 million shares. The market absorbed the potential supply without a collapse, an early sign that lockup digestion can be orderly.

The unlock event

The tranche was the first in a deliberately staggered lockup structure, triggered by the Q2 earnings release on August 4. The public float expanded from roughly 4.9% to 5% of shares outstanding to approximately 11% to 12%. A potential additional 10% price-contingent tranche did not trigger because the stock never sustained the required 30% premium to the $135 IPO price. Elon Musk's ~6.4 billion shares and certain significant investors remain locked until mid-2027 under a 366-day restriction with no early release.

Why the digestion was orderly

Several factors helped the market absorb the unlock. Much of the expected supply pressure had already been priced in during the post-earnings decline on August 5. The staggered design meant only the first tranche unlocked, with further releases spread across August through December 2026. Eligibility does not equal automatic selling; many early holders, especially those with low cost basis, may be holding or selling gradually. Elevated short interest, previously estimated in the 25% to 35% of float range, likely contributed covering pressure once the stock stabilized. Wall Street remained broadly constructive on the long-term thesis despite near-term supply concerns. And the single largest potential supply block, Musk's stake, remains unavailable until 2027.

Remaining calendar

The August 6 event was the largest single tranche but not the last. Upcoming releases include a day-70 calendar tranche around August 20 to 21 of roughly 319 million shares, additional ~7% calendar tranches in September and October, a large ~28% tranche of about 1.3 billion shares after Q3 earnings in late October or early November, and a residual 180-day unlock on December 8. By late 2026, the free float is expected to expand substantially further, though still far short of full dilution.

Implications

The positive signal from August 6 is that the market can absorb a very large eligibility event without panic. It reduced the most acute float scarcity premium risk that had amplified volatility since the June IPO. It also supports the view that not every unlock produces a mechanical selloff.

Remaining risks include cumulative supply from subsequent tranches if actual selling proves heavier than expected. High absolute valuation and elevated capital expenditure plans, highlighted in Q2 earnings, leave limited room for disappointment. Short interest may rebuild or shift as the float expands.

The first major lockup digestion passed more constructively than many feared. Attention now shifts from the single large event to the multi-month staggered supply schedule and underlying operating trends, including Starlink growth, AI compute plans, and Starship progress. The stock remains highly sensitive to both supply news and fundamental execution.